{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:42:33Z","timestamp":1781628153820,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bioorg.2025.108308","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T02:37:54Z","timestamp":1740710274000},"page":"108308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Discovery and evaluation of novel Benzohydroxamic acid-indole derivatives as dual inhibitors of ADAM17 and HDAC2 with antitumor activity"],"prefix":"10.1016","volume":"157","author":[{"given":"Xiaoxuan","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengkang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghua","family":"Xun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muxuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanbo","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aigang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2025.108308_bb0005","doi-asserted-by":"crossref","DOI":"10.1177\/1073274817729245","article-title":"Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"24","author":"Massarweh","year":"2017","journal-title":"Cancer Control"},{"key":"10.1016\/j.bioorg.2025.108308_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ebiom.2019.07.058","article-title":"Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling","volume":"46","author":"Wang","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108308_bb0015","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13045-021-01164-5","article-title":"Combination strategies to maximize the benefits of cancer immunotherapy","volume":"14","author":"Zhu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108308_bb0020","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1186\/s12885-021-08520-1","article-title":"Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer","volume":"21","author":"Gao","year":"2021","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108308_bb0025","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108308_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030521","article-title":"Notch signaling regulation in HCC: from hepatitis virus to non-coding RNAs","volume":"10","author":"Giovannini","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108308_bb0035","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","article-title":"Notch signaling pathway in cancer: from mechanistic insights to targeted therapies","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.108308_bb0040","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.2147\/OTT.S92945","article-title":"Prognostic value of Notch-1 expression in hepatocellular carcinoma: a meta-analysis","volume":"8","author":"Wu","year":"2015","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.bioorg.2025.108308_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117343","article-title":"Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo","volume":"244","author":"Lu","year":"2020","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108308_bb0050","doi-asserted-by":"crossref","first-page":"996","DOI":"10.7150\/jca.12135","article-title":"The histone deacetylase inhibitor Vaproic acid induces cell growth arrest in hepatocellular carcinoma cells via suppressing notch signaling","volume":"6","author":"Sun","year":"2015","journal-title":"J. Cancer"},{"key":"10.1016\/j.bioorg.2025.108308_bb0055","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.omto.2020.08.003","article-title":"HDAC inhibitor LBH589 suppresses the proliferation but enhances the Antileukemic effect of human \u03b3\u03b4T cells","volume":"18","author":"He","year":"2020","journal-title":"Mol Ther Oncolytics"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108308_bb0060","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.3892\/or.2015.4263","article-title":"HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a southeast Asian population","volume":"34","author":"Ler","year":"2015","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108308_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028103","article-title":"Aberrant regulation of HDAC2 mediates proliferation of hepatocellular carcinoma cells by deregulating expression of G1\/S cell cycle proteins","volume":"6","author":"Noh","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108308_bb0070","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41419-024-06981-3","article-title":"HDAC2 promotes autophagy-associated HCC malignant progression by transcriptionally activating LAPTM4B","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2025.108308_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128846","article-title":"Exploration of 4-(1H-indol-3-yl)cyclohex-3-en-1-amine analogues as HDAC inhibitors: design, synthesis, biological evaluation and modelling studies","volume":"72","author":"Zhu","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108308_bb0080","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1021\/jm0491703","article-title":"A comparison of the binding sites of matrix metalloproteinases and tumor necrosis factor-alpha converting enzyme: implications for selectivity","volume":"48","author":"Lukacova","year":"2005","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108308_bb0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1747-0285.2010.00950.x","article-title":"Tumor necrosis factor alpha converting enzyme: an encouraging target for various inflammatory disorders","volume":"75","author":"Bahia","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108308_bb0090","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1021\/acsmedchemlett.2c00272","article-title":"Fragment-based discovery of a novel, brain penetrant, orally active HDAC2 inhibitor","volume":"13","author":"Tamanini","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108308_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.abb.2006.03.034","article-title":"IK682, a tight binding inhibitor of TACE","volume":"451","author":"Niu","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"issue":"37","key":"10.1016\/j.bioorg.2025.108308_bb0100","doi-asserted-by":"crossref","first-page":"26926","DOI":"10.1074\/jbc.M113.490706","article-title":"Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability","volume":"288","author":"Lauffer","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108308_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12480","article-title":"A novel inhibitor of ADAM17 sensitizes colorectal cancer cells to 5-fluorouracil by reversing notch and epithelial-mesenchymal transition in vitro and in vivo","volume":"51","author":"Li","year":"2018","journal-title":"Cell Prolif."},{"issue":"23","key":"10.1016\/j.bioorg.2025.108308_bb0110","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.1039\/D0NJ01274B","article-title":"Design, synthesis, and biological evaluation of novel nicotinamide derivatives as potential histone deacetylase-3 inhibitors","volume":"44","author":"Hamoud","year":"2020","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2025.108308_bb0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejmech.2018.02.011","article-title":"Design, synthesis, and biological evaluation of novel amide and hydrazide based thioether analogs targeting histone deacteylase (HDAC) enzymes","volume":"148","author":"Farag","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"17","key":"10.1016\/j.bioorg.2025.108308_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26175151","article-title":"Non-Hydroxamate zinc-binding groups as warheads for histone deacetylases","volume":"26","author":"Fr\u00fchauf","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108308_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116364","article-title":"The role of the methoxy group in approved drugs","volume":"273","author":"Chiodi","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108308_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200548","article-title":"Anticancer agents incorporating the N-acylhydrazone scaffold: Progress from 2017 to present","volume":"356","author":"Kassab","year":"2023","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.bioorg.2025.108308_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138012","article-title":"Hydrazide-hydrazone\/hydrazone as enabling linkers in anti-cancer drug discovery: a comprehensive review","volume":"1307","author":"Murugappan","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"46","key":"10.1016\/j.bioorg.2025.108308_bb0140","doi-asserted-by":"crossref","first-page":"75441","DOI":"10.18632\/oncotarget.12254","article-title":"TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors","volume":"7","author":"He","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2025.108308_bb0145","doi-asserted-by":"crossref","DOI":"10.1177\/15330338241239139","article-title":"Identification of novel Cuproptosis-related genes mediating the prognosis and immune microenvironment in cholangiocarcinoma","volume":"23","author":"Liu","year":"2024","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.bioorg.2025.108308_bb0150","doi-asserted-by":"crossref","first-page":"15359","DOI":"10.1007\/s13277-016-5418-y","article-title":"The role of ADAM17 in tumorigenesis and progression of breast cancer","volume":"37","author":"Shen","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.bioorg.2025.108308_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2020.101649","article-title":"MiR-646 prevents proliferation and progression of human breast cancer cell lines by suppressing HDAC2 expression","volume":"53","author":"Darvishi","year":"2020","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.bioorg.2025.108308_bb0160","doi-asserted-by":"crossref","unstructured":"Chi M, Jie Y, Li Y, Wang D, Li M, Li D, E M, Li Y, Liu N, Gu A et al: Novel structured ADAM17 small-molecule inhibitor represses ADAM17\/notch pathway activation and the NSCLC cells' resistance to anti-tumour drugs. Front. Pharmacol. 2023, 14:1189245.","DOI":"10.3389\/fphar.2023.1189245"},{"key":"10.1016\/j.bioorg.2025.108308_bb0165","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.biopha.2016.09.030","article-title":"HDAC2 promotes the migration and invasion of non-small cell lung cancer cells via upregulation of fibronectin","volume":"84","author":"Li","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108308_bb0170","first-page":"9","article-title":"Current advances in CETSA","author":"Tolvanen","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bioorg.2025.108308_bb0175","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"W1","key":"10.1016\/j.bioorg.2025.108308_bb0180","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108308_bb0185","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41596-023-00942-4","article-title":"OptADMET: a web-based tool for substructure modifications to improve ADMET properties of lead compounds","volume":"19","author":"Yi","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2025.108308_bb0190","series-title":"OECD: Test No. 423: Acute Oral Toxicity - Acute Toxic Class Method","year":"2002"},{"key":"10.1016\/j.bioorg.2025.108308_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116729","article-title":"Discovery of a novel Xanthone derivative P24 for anti-AD via targeting sTGFBR3","volume":"276","author":"Zhou","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108308_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114701","article-title":"Development and structure-activity relationship of tacrine derivatives as highly potent CDK2\/9 inhibitors for the treatment of cancer","volume":"242","author":"Wu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108308_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114095","article-title":"Discovery of novel \u03b2-carboline derivatives as selective AChE inhibitors with GSK-3\u03b2 inhibitory property for the treatment of Alzheimer\u2019s disease","volume":"229","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."}],"updated-by":[{"DOI":"10.1016\/j.bioorg.2025.108765","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000}}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825001889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825001889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T21:32:08Z","timestamp":1763847128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825001889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":41,"alternative-id":["S0045206825001889"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108308","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and evaluation of novel Benzohydroxamic acid-indole derivatives as dual inhibitors of ADAM17 and HDAC2 with antitumor activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108308"}}